Patient info

Ezetimibe 10 mg tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
10 mg
Contains active substance:
ATC code:

Patient leaflet - Ezetimibe 10 mg tablets

1. What Ezetimibe is and what it is used for

Ezetimibe is a medicine to lower increased levels of cholesterol.

Ezetimibe lowers levels of total cholesterol, “bad” cholesterol (LDL cholesterol), and fatty substances called triglycerides in the blood. In addition, Ezetimibe raises levels of “good” cholesterol (HDLcholesterol).

Ezetimibe, the active ingredient of Ezetimibe, works by reducing the cholesterol absorbed in your digestive tract.

Ezetimibe adds to the cholesterol lowering effect of statins, a group of medicines that reduce the cholesterol your body makes by itself.

Cholesterol is one of several fatty substances found in the bloodstream. Your total cholester-ol is made up mainly of LDL and HDL cholesterol.

LDL cholesterol is often called “bad” cholesterol because it can build up in the walls of your arteries forming plaque. Eventually this plaque build-up can lead to a narrowing of the arteries. This narrowing can slow or block blood flow to vital organs such as the heart and brain. This blocking of blood flow can result in a heart attack or stroke.

HDL cholesterol is often called “good” cholesterol because it helps keep the bad cholesterol from building up in the arteries and protects against heart disease.

Triglycerides are another form of fat in your blood that may increase your risk for heart disease.

It is used for patients who cannot control their cholesterol levels by cholesterol lowering diet alone. You should stay on your cholesterol lowering diet while taking this medicine.

Ezetimibe is used in addition to your cholesterol lowering diet if you have:

  • a raised cholesterol level in your blood (primary hypercholesterolaemia [heterozygous familial and non-familial])

    • together with a statin, when your cholesterol level is not well controlled with a statin alone
    • alone, when statin treatment is inappropriate or is not tolerated
  • a hereditary illness (homozygous familial hypercholesterolaemia) that increases the cholesterol level in your blood. You will also be prescribed a statin and may also receive other treatments.
  • a hereditary illness (homozygous sitosterolaemia, also known as phytosterolae- mia) that increases the levels of plant sterols in your blood.

If you have heart disease, Ezetimibe combined with cholesterol lowering medicines called statins reduces the risk of heart attack, stroke, surgery to increase heart blood flow, or hospitalisation for chest pain.

Ezetimibe does not help you lose weight.

2. What you need to know before you take Ezetimibe

If you use Ezetimibe together with a statin, please read the package leaflet of that particular medicine.

Do not take Ezetimibe if:

  • you are allergic (hypersensitive) to ezetimibe or any of the other ingredients of this medicine (see section 6: Contents of the pack and other information).

Do not take Ezetimibe together with a statin if:

  • you currently have liver problems.
  • you are pregnant or breast-feeding.

Warnings and precautions

Talk to your doctor or pharmacist before taking Ezetimibe:

  • Tell your doctor about all your medical conditions including allergies.
  • Your doctor should do a blood test before you start taking Ezetimibe with a statin. This is to check how well your liver is working.
  • Your doctor may also want you to have blood tests to check how well your liver is working after you start taking Ezetimibe with a statin.

If you have moderate or severe liver problems, Ezetimibe is not recommended.

The safety and efficacy of the combined use of Ezetimibe and certain cholesterol lowering medicines, the fibrates have not been established.

Children and adolescents

Do not give this medicine to children and adolescents (6 to 17 years of age) unless prescribed by a specialist because there are limited data on safety and efficacy.

Do not give this medicine to children less than 6 years old because there is no information in this age group.

Other medicines and Ezetimibe

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. In particular, tell your doctor if you are taking medicine(s) with any of the following active ingredients:

  • ciclosporin (often used in organ transplant patients)
  • medicines with an active ingredient to prevent blood clots, such as warfarin, phenpro-coumon, acenocoumarol or fluindione (anticoagulants)
  • colestyramine (also used to lower cholesterol), because it affects the way Ezetimibe works
  • fibrates (also used to lower cholesterol)

Pregnancy and breast-feeding

Do not take Ezetimibe with a statin if you are pregnant, are trying to get pregnant or think you may be pregnant. If you get pregnant while taking Ezetimibe with a statin, stop taking both medicines immediately and tell your doctor.

There is no experience from the use of Ezetimibe without a statin during pregnancy. Ask your doctor for advice before using Ezetimibe if you are pregnant.

Do not take Ezetimibe with a statin if you are breast-feeding, because it is not known if the medicines are passed into breast milk.

Ezetimibe without a statin should not be used if you are breast-feeding. Ask your doctor for advice.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Ezetimibe is not expected to interfere with your ability to drive or to use machinery. However, it should be taken into account that some people may get dizzy after taking Ezetimibe.

Ezetimibe contains Lactose

Ezetimibe tablets contain a sugar called lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

120 mm

Size: 120 x 520 mm

Ezetimibe contains Sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium free’.

3. How to take Ezetimibe

Always take this medicine exactly as your doctor has told you. Continue taking your other cholesterol lowering medicines unless your doctor tells you to stop. You should check with your doctor or pharmacist if you are not sure.

  • Before starting Ezetimibe, you should be on a diet to lower your cholesterol.
  • You should keep on this cholesterol lowering diet whilst taking Ezetimibe.

The recommended dose is one Ezetimibe 10 mg Tablet by mouth once a day.

Take Ezetimibe at any time of the day. You can take it with or without food. If your doctor has prescribed Ezetimibe along with a statin, both medicines can be taken at the same time. In this case, please read the dosage instructions in the package leaflet of that particular medicine.

If your doctor has prescribed Ezetimibe along with another medicine for lowering cholesterol containing the active ingredient colestyramine or any other medicine containing bile acid sequestrant, you should take Ezetimibe at least 2 hours before or 4 hours after taking the bile acid sequestrant.

If you take more Ezetimibe than you should

Please contact your doctor or pharmacist.

If you forget to take Ezetimibe

Do not take a double dose to make up for a forgotten tablet, just take your normal amount of Ezetimibe at the usual time the next day.

If you stop taking Ezetimibe

Talk to your doctor or pharmacist because your cholesterol may rise again. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following terms are used to describe how often side effects have been reported:

  • Very common (may affect more than 1 of 10 patients)
  • Common (may affect up to 1 of 10 patients)
  • Uncommon (may affect up to 1 of 100 patients)
  • Rare (may affect up to 1 of 1,000 patients)
  • Very rare (may affect up to 1 of 10,000 patients, including isolated reports).

Contact your doctor immediately if you experience unexplained muscle pain, tenderness, or weakness. This is because on rare occasions, muscle problems, including muscle breakdown resulting in kidney damage, can be serious and may become a potentially life-threatening condition.

Allergic reactions, including swelling of the face, lips, tongue, and/or throat that may cause difficulty in breathing or swallowing (which requires treatment right away) have been reported in general use.

When used alone, the following side effects were reported:

Common: abdominal pain; diarrhoea; flatulence; feeling tired.

Uncommon: elevations in some laboratory blood tests of liver (transaminases) or muscle (CK) function; cough; indigestion; heartburn; nausea; joint pain; muscle spasms; neck pain; decreased appetite, pain, chest pain, hot flush; high blood pressure.

Additionally, when used with a statin, the following side effects were reported: Common: elevations in some laboratory blood tests of liver function (transaminases); headache; muscle pain, tenderness or weakness.

Uncommon: tingling sensation; dry mouth; itching; rash; hives; back pain; muscle weakness; pain in arms and legs; unusual tiredness or weakness; swelling, especially in the hands and feet.

When used with fenofibrate, the following common side effect was reported: abdominal pain.

Additionally, the following side effects have been reported in general use: dizziness; muscle aches; liver problems; allergic reactions including rash and hives; raised red rash, sometimes with target-shaped lesions (erythema multiforme); muscle pain, tenderness or weakness; muscle breakdown; gallstones or inflammation of the gallbladder (which may cause abdominal pain, nausea, vomiting); inflammation of the pancreas often with severe abdominal pain; constipation, reduction in blood cell counts, which may cause bruising/ bleeding (thrombocytopaenia); tingling sensation; depression: unusual tiredness or weakness; shortness of breath.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Ezetimibe

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP.

The expiry date refers to the last day of that month.

Store in the original package in order to protect from moisture.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Ezetimibe contains

  • The active substance is ezetimibe. Each tablet contains 10 mg ezetimibe.
  • The other ingredients: lactose monohydrate, microcrystalline cellulose, croscar- mellose sodium, povidone, sodium laurilsulfate, magnesium stearate.

What Ezetimibe looks like and contents of the pack

Ezetimibe tablets are white to off white, capsule shaped, tablets debossed with “J7” on one side. The tablets are approximately 8 mm in length and 4 mm in width.

Pack sizes: 28, 56 or 112 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Perennial Pharma Ltd

Titan Court, 2nd Floor,

3 Bishop Square,

Hatfield,

AL10 9NA,

United Kingdom

Manufacturer

GMP Manufacturing Ltd.

Park Royal House and Marfleet House,

Valletta Street,

Hull,

HU9 5NP

United Kingdom

This leaflet was last revised in 06/2026

For information in large print, Braille or on CD, telephone 01707 927427.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 52835/0006

Last revision stated in the text: June 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Ezetimibe 10 mg tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Ezetimibe
Strength 10 mg
Pharmaceutical form Oral tablet
White to off – white, capsule shaped, flat beveled edged, uncoated tablets debossed with ‘EZE’ on one side and plain on other side, approximately
8.2mm in length and 4.1mm in width
How is it taken Oral
Excipients Lactose Monohydrate, Croscarmellose Sodium, Sodium Lauryl Sulphate, Hypromellose, Colloidal Silicon Dioxide Microcrystalline Cellulose Hydrogenated Castor Oil, Sodium Stearyl Fumarate
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage Keep in the outer carton in order to protect from moisture.
Drug group (ATC) Other lipid modifying agents
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AX Other lipid modifying agents
          1. C10AX09 ezetimibe
Marketing authorisation PL 20416/1219 (first authorised 24 July 2026), PL 52835/0006
Marketing authorisation holder Crescent Pharma Limited
Codes GTIN 5060995410074 · BNF 02120000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.